Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
11%
ALSO IN IDNA
IDNA
52
HOLDINGS
30%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
ROCHE HOLDING LTD | 3.9% | 4.1% | 3.9% |
 |
MERCK & CO. INC. | 3.3% | 3.9% | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 1.5% | 3.7% | 1.5% |
 |
SANOFI-AVENTIS | 1.2% | 3.4% | 1.2% |
 |
GSK PLC | 1.2% | 3.6% | 1.2% |
IXJ Overweight Relative to IDNA
|
ELI LILLY & CO | 10.4% |
|
JOHNSON & JOHNSON | 6.5% |
|
ABBVIE INC | 4.8% |
|
UNITEDHEALTH GROUP INC | 4.0% |
|
ASTRAZENECA PLC | 3.5% |
|
NOVARTIS AG | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
 |
NOVO NORDISK A/S-B | 2.5% |
|
ABBOTT LABORATORIES | 2.3% |
|
INTUITIVE SURGICAL INC | 2.3% |
IXJ Underweight Relative to IDNA
|
MODERNA, INC. | -6.1% |
|
REVOLUTION MEDICINES, INC. | -5.3% |
 |
BIONTECH SE SPONSORED ADR | -4.3% |
|
BAYER AG | -4.2% |
|
IPSEN | -4.1% |
|
EXELIXIS INC | -3.6% |
|
GENMAB A/S | -3.5% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -3.5% |
|
INCYTE CORP | -3.4% |
|
ARCELLX, INC. | -3.1% |